Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Minerva Neurosciences Inc
NERVCurrent price
2.32 USD
-0.18 USD (-7.20%)
Last closed
2.62 USD
Company
www.minervaneurosciences.com
ISIN
US6033801068
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
18 322 734 USD
Yield for 12 month
-57.04 %
1Y
3Y
5Y
10Y
15Y
NERV
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. The company has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts. Address: 1500 District Avenue, Burlington, MA, United States, 01803
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-30 982 USD
Last Year
-8 513 USD
Current Quarter
-7 746 USD
Last Quarter
-7 745 USD
Key Figures NERV
1 year
3 years
5 years
10 years
EBITDA
-26 205 152 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-28.88 %
PEG Ratio
–
Return On Equity TTM
-675.09 %
Wall Street Target Price
5 USD
Revenue TTM
–
Book Value
-6.36 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
-16 838 947 USD
Earnings per share
-4.4 USD
Diluted Eps TTM
-4.4 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics NERV
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NERV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:8
Payout Ratio
–
Last Split Date
21.06.2022
Dividend Date
–
Stock Valuation NERV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
11.2108
Enterprise Value Revenue
0.0345
Price Sales TTM
1.868
Enterprise Value EBITDA
2.6004
Price Book MRQ
2.6783
Financials NERV
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NERV
For 52 weeks
2.26 USD
13.49 USD
50 Day MA
2.66 USD
Shares Short Prior Month
9 614
200 Day MA
3.55 USD
Short Ratio
0.63
Shares Short
7 205
Short Percent
0.17 %
BeatStart